Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models.

Solari N, Bonito-Oliva A, Fisone G, Brambilla R.

Learn Mem. 2013 Sep 18;20(10):592-600. doi: 10.1101/lm.032029.113. Review.

PMID:
24049188
2.

A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.

Zgaljardic DJ, Borod JC, Foldi NS, Mattis P.

Cogn Behav Neurol. 2003 Dec;16(4):193-210. Review.

PMID:
14665819
3.

The impact and management of nonmotor symptoms of Parkinson's disease.

Lyons KE, Pahwa R.

Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Review.

4.

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.

Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV.

Brain. 1991 Oct;114 ( Pt 5):2095-122.

PMID:
1933236
5.

Premotor symptoms and early diagnosis of Parkinson's disease.

Adler CH.

Int J Neurosci. 2011;121 Suppl 2:3-8. doi: 10.3109/00207454.2011.620192. Review.

PMID:
22035024
6.

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.

Vu TC, Nutt JG, Holford NH.

Br J Clin Pharmacol. 2012 Aug;74(2):267-83. doi: 10.1111/j.1365-2125.2012.04192.x.

7.

The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.

Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R.

Curr Pharm Des. 2011;17(5):489-507. Review.

PMID:
21375482
8.

Neurodegeneration and cognition in Parkinson's disease: a review.

Ding W, Ding LJ, Li FF, Han Y, Mu L.

Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2275-81. Review.

9.

Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.

Hepp DH, da Hora CC, Koene T, Uitdehaag BM, van den Heuvel OA, Klein M, van de Berg WD, Berendse HW, Foncke EM.

Parkinsonism Relat Disord. 2013 Sep;19(9):795-9. doi: 10.1016/j.parkreldis.2013.04.026. Epub 2013 May 21.

PMID:
23706540
10.

[Correlation between cognitive impairment and postural instability in patients with Parkinson's disease].

Owan Y, Murakami H, Mori Y, Yamagishi K, Watanabe D, Kato H, Kezuka M, Kawamura M.

Brain Nerve. 2015 Jan;67(1):99-104. doi: 10.11477/mf.1416200092. Japanese.

PMID:
25585439
11.

Nonmotor Symptoms in Experimental Models of Parkinson's Disease.

Titova N, Schapira AHV, Chaudhuri KR, Qamar MA, Katunina E, Jenner P.

Int Rev Neurobiol. 2017;133:63-89. doi: 10.1016/bs.irn.2017.05.018. Epub 2017 Jul 10. Review.

PMID:
28802936
12.

Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.

Lewis SJ, Cools R, Robbins TW, Dove A, Barker RA, Owen AM.

Neuropsychologia. 2003;41(6):645-54.

PMID:
12591022
13.

[Impairment of social cognition in Parkinson's disease].

Yoshimura N, Kawamura M.

No To Shinkei. 2005 Feb;57(2):107-13. Review. Japanese.

PMID:
15856756
14.

The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.

Domellöf ME, Elgh E, Forsgren L.

Mov Disord. 2011 Oct;26(12):2183-9. doi: 10.1002/mds.23814. Epub 2011 Jun 9.

PMID:
21661051
15.

Aberrant dopamine transmission and cognitive dysfunction in animal models of Parkinson's disease.

Lelos MJ, Dunnett SB.

J Parkinsons Dis. 2011;1(2):151-65. doi: 10.3233/JPD-2011-11036. Review.

PMID:
23934917
16.

Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients.

Erro R, Santangelo G, Picillo M, Vitale C, Amboni M, Longo K, Giordano F, Moccia M, Barone P, Pellecchia MT.

Parkinsonism Relat Disord. 2013 Feb;19(2):256-9. doi: 10.1016/j.parkreldis.2012.10.020. Epub 2012 Nov 22.

PMID:
23178144
17.

Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.

Weerkamp NJ, Tissingh G, Poels PJ, Zuidema SU, Munneke M, Koopmans RT, Bloem BR.

J Am Geriatr Soc. 2013 Oct;61(10):1714-21. doi: 10.1111/jgs.12458. Epub 2013 Oct 1.

PMID:
24117286
18.

Interrelations between cognitive dysfunction and motor symptoms of Parkinson's disease: behavioral and neural studies.

Moustafa AA, Chakravarthy S, Phillips JR, Crouse JJ, Gupta A, Frank MJ, Hall JM, Jahanshahi M.

Rev Neurosci. 2016 Jul 1;27(5):535-48. doi: 10.1515/revneuro-2015-0070. Review.

PMID:
26982614
19.

Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.

Fifel K, Dkhissi-Benyahya O, Cooper HM.

Chronobiol Int. 2013 Jul;30(6):741-55. doi: 10.3109/07420528.2012.762011. Epub 2013 Jun 12.

PMID:
23758587
20.

Non-motor extranigral signs and symptoms in Parkinson's disease.

Wolters ECh.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9. Review.

PMID:
20083010

Supplemental Content

Support Center